ProShares Ultra Nasdaq Biotechnology Rating $52.55 -0.07 (-0.13%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$53.34 +0.79 (+1.50%) As of 07/25/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.69Holdings in BIB have an aggregate rating of Moderate Buy based on 679 analyst ratings issued in the past year covering 44 companies (55.7% of the portfolio).BIB Aggregate Price Target$52.55High Prediction$52.55Average Prediction$52.55Low Prediction$52.55Holdings in BIB have an aggregate price target of $52.55 and a range of $52.55 to $52.55 covering 44 companies (55.7% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.57%GILDGilead Sciences$116.20+2.7%4.8879 of 5 stars2.81$112.36 -3.3%26Trending NewsAnalyst Upgrade5.53%VRTXVertex Pharmaceuticals$469.65-0.6%4.3226 of 5 stars2.52$512.30 9.1%27Positive NewsAnalyst Revision5.33%AMGNAmgen$306.58-0.6%4.4062 of 5 stars2.35$307.27 0.2%23Positive NewsAnalyst Forecast4.39%REGNRegeneron Pharmaceuticals$563.10-0.3%4.8268 of 5 stars2.75$828.86 47.2%24Trending NewsUpcoming EarningsAnalyst Forecast3.30%AZNAstraZeneca$72.66-1.4%2.9427 of 5 stars2.83$89.00 22.5%6Upcoming Earnings2.94%ALNYAlnylam Pharmaceuticals$328.81+0.2%4.0702 of 5 stars2.81$347.75 5.8%26News CoveragePositive NewsUpcoming Earnings1.48%BIIBBiogen$131.52-0.8%4.8086 of 5 stars2.34$186.37 41.7%32Upcoming EarningsAnalyst Revision1.45%INSMInsmed$103.95+0.4%3.9267 of 5 stars3.00$109.20 5.1%17News CoverageAnalyst ForecastInsider Trade1.42%ARGXargenex$591.99+0.0%3.6719 of 5 stars3.10$728.06 23.0%21Trending NewsUpcoming EarningsAnalyst Revision1.23%SMMTSummit Therapeutics$28.67+4.0%2.512 of 5 stars2.79$34.67 20.9%14Positive News1.21%RPRXRoyalty Pharma$36.67+0.2%4.9759 of 5 stars3.25$49.00 33.6%4Positive NewsDividend AnnouncementAnalyst Forecast1.20%ILMNIllumina$109.30+1.5%4.6269 of 5 stars2.40$125.11 14.5%20News CoverageUpcoming Earnings1.08%SNYSanofi$50.37+0.5%3.547 of 5 stars3.13$62.00 23.1%8Positive NewsUpcoming Earnings1.06%INCYIncyte$70.20-0.4%4.6277 of 5 stars2.22$74.47 6.1%18Positive NewsUpcoming EarningsInsider Trade1.03%UTHRUnited Therapeutics$304.50-0.6%4.991 of 5 stars2.69$383.08 25.8%13Trending NewsUpcoming EarningsInsider TradeAnalyst Revision0.99%NBIXNeurocrine Biosciences$132.14+0.4%4.4413 of 5 stars2.88$163.87 24.0%24Upcoming EarningsAnalyst Forecast0.95%EXELExelixis$45.60+1.8%4.7783 of 5 stars2.52$45.33 -0.6%21News CoveragePositive NewsUpcoming EarningsAnalyst Forecast0.90%TEMTempus AI$64.49+1.8%1.584 of 5 stars2.50$65.09 0.9%120.85%VTRSViatris$9.41+0.6%2.4337 of 5 stars1.80$10.40 10.5%50.85%BNTXBioNTech$115.31+0.6%1.4352 of 5 stars2.83$136.58 18.4%18News Coverage0.85%BMRNBioMarin Pharmaceutical$59.01-1.3%4.9857 of 5 stars2.75$93.74 58.9%24Analyst Forecast0.84%ASNDAscendis Pharma A/S$167.47-0.5%3.4327 of 5 stars3.00$223.07 33.2%15Analyst Revision0.84%MRNAModerna$34.15+0.4%4.2995 of 5 stars2.04$46.11 35.0%25Upcoming EarningsAnalyst Forecast0.80%ONCBeOne Medicines$291.47-1.7%1.2901 of 5 stars3.00$327.56 12.4%7Analyst UpgradeInsider Trade0.72%MEDPMedpace$447.49-1.8%3.7182 of 5 stars2.00$411.10 -8.1%14Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Down0.68%BBIOBridgeBio Pharma$46.30+1.4%4.6357 of 5 stars3.00$61.50 32.8%16Analyst Downgrade0.66%BPMCBlueprint Medicines$129.461.0836 of 5 stars2.24$128.25 -0.9%21Positive NewsUpcoming Earnings0.62%ROIVRoivant Sciences$11.55+1.5%2.5987 of 5 stars3.25$16.50 42.9%4News CoveragePositive NewsInsider Trade0.59%VRNAVerona Pharma PLC American Depositary Share$105.30+0.3%2.8206 of 5 stars2.15$109.00 3.5%13Positive News0.55%RVMDRevolution Medicines$37.90+1.8%4.4972 of 5 stars3.00$68.91 81.8%11News Coverage0.53%JAZZJazz Pharmaceuticals$118.23+0.2%4.8614 of 5 stars2.93$181.64 53.6%14Analyst Forecast0.53%MDGLMadrigal Pharmaceuticals$298.40-0.3%4.3095 of 5 stars2.89$420.63 41.0%9News CoverageInsider Trade0.52%HALOHalozyme Therapeutics$58.24-0.9%4.8524 of 5 stars2.17$62.70 7.7%12Positive News0.51%IONSIonis Pharmaceuticals$42.24+0.2%4.5355 of 5 stars2.62$55.67 31.8%13News CoverageUpcoming Earnings0.50%GHGuardant Health$44.42-2.4%4.4699 of 5 stars3.05$54.45 22.6%21News CoverageUpcoming EarningsAnalyst Revision0.42%NUVLNuvalent$81.41-0.8%3.203 of 5 stars3.17$119.60 46.9%12High Trading Volume0.41%AXSMAxsome Therapeutics$100.83-3.9%4.744 of 5 stars3.06$172.33 70.9%16News CoveragePositive NewsAnalyst Revision0.38%ALKSAlkermes$26.13-1.5%4.7871 of 5 stars2.83$40.92 56.6%12Upcoming Earnings0.36%AKROAkero Therapeutics$50.56+0.1%3.8187 of 5 stars3.00$82.50 63.2%6Positive News0.35%ADMAADMA Biologics$18.01+4.0%3.6147 of 5 stars3.33$27.67 53.6%3News CoveragePositive News0.34%PCVXVaxcyte$36.63+1.1%1.8035 of 5 stars3.10$136.50 272.6%10News CoveragePositive News0.33%CRSPCRISPR Therapeutics$64.76-2.0%2.4864 of 5 stars2.53$71.31 10.1%17Analyst ForecastGap Up0.32%RYTMRhythm Pharmaceuticals$86.45-0.9%3.128 of 5 stars3.07$91.93 6.3%15Analyst Upgrade0.32%KRYSKrystal Biotech$147.61-1.6%4.893 of 5 stars3.00$211.33 43.2%10News CoverageAnalyst Forecast This page (NASDAQ:BIB) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts